Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Goldhardt

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
BMC Neurology|November 2, 2019
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's diseaseMarion Ortner, René Drost, Dennis Hedderich, et al.
BMC Neurology|March 7, 2020
Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's diseaseMarion Ortner, René Drost, Dennis Hedderich, et al.
Journal of Alzheimer'S Disease : JAD|September 4, 2018
Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain VolumetryDennis M Hedderich, Judith E Spiro, Oliver Goldhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
Integrity of Neurocognitive Networks in Dementing Disorders as Measured with Simultaneous PET/Functional MRIIsabelle Ripp, Thomas Stadhouders, Alexandre Savio, et al.
Frontiers in Psychiatry|September 9, 2020
Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer's DiseaseDennis M Hedderich, René Drost, Oliver Goldhardt, et al.
Frontiers in Pharmacology|June 9, 2020
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended LevelsMarion Ortner, Marion Stange, Heike Schneider, et al.
Neuroimage. Clinical|March 6, 2014
LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's Disease in humans in-vivoTimo Grimmer, Oliver Goldhardt, Liang-Hao Guo, et al.
Journal of Alzheimer'S Disease : JAD|May 22, 2023
Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel DiseaseMarion Ortner, Korbinian Lanz, Oliver Goldhardt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2022
Herpes simplex virus alters Alzheimer's disease biomarkers - A hypothesis paperOliver Goldhardt, Robert Freiberger, Tobias Dreyer, et al.
International Psychogeriatrics|October 2, 2015
Trends of patient referral to a memory clinic and towards earlier diagnosis from 1985-2009Timo Grimmer, Stephanie Beringer, Victoria Kehl, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
BMC Neurology|November 2, 2019
Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's diseaseMarion Ortner, René Drost, Dennis Hedderich, et al.
BMC Neurology|March 7, 2020
Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's diseaseMarion Ortner, René Drost, Dennis Hedderich, et al.
Journal of Alzheimer'S Disease : JAD|September 4, 2018
Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain VolumetryDennis M Hedderich, Judith E Spiro, Oliver Goldhardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2020
Integrity of Neurocognitive Networks in Dementing Disorders as Measured with Simultaneous PET/Functional MRIIsabelle Ripp, Thomas Stadhouders, Alexandre Savio, et al.
Frontiers in Psychiatry|September 9, 2020
Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer's DiseaseDennis M Hedderich, René Drost, Oliver Goldhardt, et al.
Frontiers in Pharmacology|June 9, 2020
Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended LevelsMarion Ortner, Marion Stange, Heike Schneider, et al.
Neuroimage. Clinical|March 6, 2014
LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's Disease in humans in-vivoTimo Grimmer, Oliver Goldhardt, Liang-Hao Guo, et al.
Journal of Alzheimer'S Disease : JAD|May 22, 2023
Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel DiseaseMarion Ortner, Korbinian Lanz, Oliver Goldhardt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2022
Herpes simplex virus alters Alzheimer's disease biomarkers - A hypothesis paperOliver Goldhardt, Robert Freiberger, Tobias Dreyer, et al.
International Psychogeriatrics|October 2, 2015
Trends of patient referral to a memory clinic and towards earlier diagnosis from 1985-2009Timo Grimmer, Stephanie Beringer, Victoria Kehl, et al.
Pageof 4